Zelira Therapeutics Limited

CHIA:ZLD Stock Report

Market Cap: AU$7.3m

Zelira Therapeutics Management

Management criteria checks 3/4

Zelira Therapeutics' CEO is Oludare Odumosu, appointed in Jan 2021, has a tenure of 3.83 years. total yearly compensation is A$557.33K, comprised of 81% salary and 19% bonuses, including company stock and options. directly owns 1.16% of the company’s shares, worth A$84.33K. The average tenure of the management team and the board of directors is 4.9 years and 4.9 years respectively.

Key information

Oludare Odumosu

Chief executive officer

AU$557.3k

Total compensation

CEO salary percentage81.0%
CEO tenure3.8yrs
CEO ownership1.2%
Management average tenure4.9yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Oludare Odumosu's remuneration changed compared to Zelira Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$557kAU$451k

-AU$37m

Mar 31 2024n/an/a

-AU$36m

Dec 31 2023n/an/a

-AU$36m

Sep 30 2023n/an/a

-AU$21m

Jun 30 2023AU$479kAU$445k

-AU$6m

Mar 31 2023n/an/a

-AU$8m

Dec 31 2022n/an/a

-AU$10m

Sep 30 2022n/an/a

-AU$11m

Jun 30 2022AU$642kAU$449k

-AU$12m

Mar 31 2022n/an/a

-AU$11m

Dec 31 2021n/an/a

-AU$10m

Sep 30 2021n/an/a

-AU$9m

Jun 30 2021AU$560kAU$318k

-AU$9m

Mar 31 2021n/an/a

-AU$8m

Dec 31 2020n/an/a

-AU$8m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$321kAU$114k

-AU$7m

Compensation vs Market: Oludare's total compensation ($USD362.18K) is about average for companies of similar size in the Australian market ($USD297.81K).

Compensation vs Earnings: Oludare's compensation has increased whilst the company is unprofitable.

CEO

Oludare Odumosu

3.8yrs

Tenure

AU$557,327

Compensation

Dr. Oludare Odumosu serves as Director of Zelira Therapeutics Limited (formerly Zelda Therapeutics Ltd) since December 02, 2019. He serves as the Managing Director & Global Chief Executive Officer of Zelir...

Leadership Team

NamePositionTenureCompensationOwnership
Osagie Imasogie
Founder & Chairman4.9yrsAU$151.31k3.78%
A$ 274.5k
Oludare Odumosu
MD, Global CEO & Director3.8yrsAU$557.33k1.16%
A$ 84.3k
Greg Blake
Executive Directorno dataAU$323.02kno data
Timothy Slate
Company Secretary & Non-Executive Director8.1yrsAU$65.18k0.069%
A$ 5.0k
Rahul Ganesan
Vice President of Finance & Accountingno datano datano data
Patty Washer
Clinical Trial Consultantno datano datano data

4.9yrs

Average Tenure

Experienced Management: ZLD's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Osagie Imasogie
Founder & Chairman4.9yrsAU$151.31k3.78%
A$ 274.5k
Oludare Odumosu
MD, Global CEO & Director4.9yrsAU$557.33k1.16%
A$ 84.3k
Greg Blake
Executive Director1.8yrsAU$323.02kno data
Timothy Slate
Company Secretary & Non-Executive Director2.8yrsAU$65.18k0.069%
A$ 5.0k
Mara Gordon
Member of Medical Advisory Boardno dataAU$12.00k2.22%
A$ 161.4k
Manuel Guzman
Member of Medical Advisory Boardno datano datano data
Cristina Sanchez
Member of Medical Advisory Boardno datano datano data
Joe Goldstrich
Member of Medical Advisory Board8.8yrsno datano data
Noah Federman
Member of Medical Advisory Board8.7yrsno datano data
David Casarett
Scientific & Medical Advisory Board6.3yrsno datano data
Dustin Sulak
Scientific & Medical Advisory Board6.3yrsno datano data
Donna O'Donnell
Independent Non-Executive Director1.4yrsAU$105.76kno data

4.9yrs

Average Tenure

Experienced Board: ZLD's board of directors are considered experienced (4.9 years average tenure).